Stockbridge Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248M | Sell |
611,951
-35,358
| -5% | -$14.3M | 4.85% | 11 |
|
|
2025
Q1 | $322M | Buy |
647,309
+80,726
| +14% | +$40.2M | 7.13% | 10 |
|
|
2024
Q4 | $295M | Sell |
566,583
-10,000
| -2% | -$5.2M | 6.25% | 9 |
|
|
2024
Q3 | $357M | Sell |
576,583
-55,835
| -9% | -$34.5M | 7.16% | 6 |
|
|
2024
Q2 | $350M | Sell |
632,418
-72,004
| -10% | -$39.8M | 7.23% | 8 |
|
|
2024
Q1 | $409M | Sell |
704,422
-21,012
| -3% | -$12.2M | 8.43% | 5 |
|
|
2023
Q4 | $385M | Buy |
725,434
+86,579
| +14% | +$46M | 8.23% | 3 |
|
|
2023
Q3 | $323M | Buy |
+638,855
| New | +$323M | 7.19% | 5 |
|